ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens. Squires KE, Mayers DL, Bluemling GR, Kolykhalov AA, et al. Antimicrob Agents Chemother 2020 Jun 15. pii: AAC.00836.

Read + Share

Amedeo Smart

Independent Medical Education

Squires KE, Mayers DL, Bluemling GR, Kolykhalov AA, et al. ATI-2173, A Novel Liver-Targeted Non-Chain Terminating Nucleotide for HBV Cure Regimens. Antimicrob Agents Chemother 2020 Jun 15. pii: AAC.00836.
PMID: 32540975